Internal Medicine, Endocrinology, Diabetes, & Metabolism · Woodbury, NY
NPI
1225119241
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
165 Froehlich Farm Blvd
Woodbury, NY, 11797
Phone (516) 364-7405
Groups this clinician bills Medicare through
Medicare paid, 2024
$472K
9,780 services
Medicare patients, 2024
999
Average age 74
Drug cost, 2024
$3.2M
5,228 prescriptions
Company payments, 2025
$18K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen F Schwartz was code 99214 (office e&m - established), 1,654 times for 895 patients. In total Karen F Schwartz billed 9,780 services in 39 codes, and Medicare paid $472K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,654 | 895 | $107.76 | $178K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 998 | 520 | $14.25 | $14K |
| 76536 Ultrasound - Nonspecific | Office | 856 | 725 | $98.48 | $84K |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 536 | 227 | $71.69 | $38K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 441 | 218 | $28.15 | $12K |
| 77085 Standard X-ray | Office | 399 | 399 | $61.53 | $25K |
| 83036 Blood Count | Office | 265 | 184 | $9.48 | $2,513 |
| 95251 Test - Miscellaneous | Office | 251 | 102 | $29.56 | $7,420 |
| 81002 Clinical Chemistry | Office | 220 | 146 | $3.41 | $750 |
| 82570 Clinical Chemistry | Office | 188 | 122 | $5.08 | $955 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 162 | 134 | $108.72 | $18K |
| 99459 Office/Outpatient Services | Office | 154 | 145 | $20.85 | $3,211 |
| 82270 Immunoassay | Office | 139 | 139 | $4.26 | $592 |
| 96372 Injection Administration | Office | 134 | 75 | $12.42 | $1,664 |
| 99215 Office E&M - Established | Office | 133 | 131 | $155.53 | $21K |
By year: 2022 $545K for 11,223 services; 2023 $574K for 19,391 services; 2024 $472K for 9,780 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 265 | 184 | $9.48 | $2,513 |
| 81002 Clinical Chemistry | 220 | 146 | $3.41 | $750 |
| 82570 Clinical Chemistry | 188 | 122 | $5.08 | $955 |
| 82270 Immunoassay | 139 | 139 | $4.26 | $592 |
Medicare prescription drug claims, 2024
In 2024, the drug Karen F Schwartz prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 644 prescriptions and refills. In total Karen F Schwartz wrote 5,228 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 644 | 1,843 | 179 | $54K |
| Mounjaro Tirzepatide | 542 | 840 | 115 | $870K |
| Levothyroxine Sodium Generic | 447 | 1,262 | 135 | $7,971 |
| Metformin Hcl Er Metformin Hcl | 370 | 1,063 | 122 | $4,868 |
| Ozempic Semaglutide | 274 | 515 | 68 | $483K |
| Trulicity Dulaglutide | 236 | 438 | 65 | $415K |
| Jardiance Empagliflozin | 201 | 478 | 56 | $276K |
| Metformin Hcl Generic | 145 | 433 | 53 | $1,652 |
| Prolia Denosumab | 133 | 798 | 76 | $226K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 116 | 311 | 43 | $13K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 110 | 249 | 31 | $95K |
| Estradiol Generic | 98 | 274 | 45 | $23K |
| Alendronate Sodium Generic | 90 | 248 | 30 | $873 |
| Raloxifene Hcl Generic | 89 | 257 | 30 | $4,500 |
| Risedronate Sodium Generic | 85 | 235 | 33 | $9,331 |
Brand drugs: 2,987 claims; generic drugs: 1,997 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen F Schwartz $18K ($18K in general payments such as food, travel and fees) from 24 companies. The largest payer was Lilly USA, LLC with $10K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 25 | $10K |
| Astellas Pharma US Inc 4503.T | 10 | $3,852 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $1,798 |
| Amgen Inc. AMGN | 19 | $554 |
| Novo Nordisk Inc NVO | 9 | $240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $173 |
| Xeris Pharmaceuticals, Inc. | 8 | $168 |
| Amneal Pharmaceuticals LLC AMRX | 7 | $144 |
| Abbvie Inc. ABBV | 12 | $135 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $98.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.